Intramuscular vascular endothelial growth factor gene therapy: fact or fiction?
Baumgartner
Iris
I
Swiss Cardiovascular Center, Division of Angiology, University Hospital, Bern, Switzerland. iris.baumgartner@insel.ch
D002908:Chronic Disease; D004247:DNA / Q000008:administration & dosage; D016228:Endothelial Growth Factors / Q000008:administration & dosage* / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007273:Injections, Intramuscular; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage* / Q000235:genetics*; D007511:Ischemia / Q000628:therapy*; D007866:Leg / Q000098:blood supply*; D008222:Lymphokines / Q000008:administration & dosage* / Q000235:genetics*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D004247:DNA